 | • レポートコード：QFJ1-4549 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、鼻ポリープ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・鼻ポリープ治療薬の市場動向 ・企業の競争状況、市場シェア ・鼻ポリープ治療薬の種類別市場規模と予測2016-2027（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他） ・鼻ポリープ治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・鼻ポリープ治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・鼻ポリープ治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・鼻ポリープ治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鼻ポリープ治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・鼻ポリープ治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Roche、Sanofi、Novartis、GlaxoSmithKline、Merck、Regeneron Pharmaceuticals） ・結論 |
Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.
Market Analysis and Insights: Global Nasal Polyps Drugs Market
The global Nasal Polyps Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nasal Polyps Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nasal Polyps Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nasal Polyps Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nasal Polyps Drugs market.
Global Nasal Polyps Drugs Scope and Market Size
Nasal Polyps Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Polyps Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Antibiotics
Leukotriene Inhibitors
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Roche
Sanofi
Novartis
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nasal Polyps Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Antibiotics
1.2.4 Leukotriene Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nasal Polyps Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nasal Polyps Drugs Market Perspective (2016-2027)
2.2 Nasal Polyps Drugs Growth Trends by Regions
2.2.1 Nasal Polyps Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nasal Polyps Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Nasal Polyps Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Nasal Polyps Drugs Industry Dynamic
2.3.1 Nasal Polyps Drugs Market Trends
2.3.2 Nasal Polyps Drugs Market Drivers
2.3.3 Nasal Polyps Drugs Market Challenges
2.3.4 Nasal Polyps Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nasal Polyps Drugs Players by Revenue
3.1.1 Global Top Nasal Polyps Drugs Players by Revenue (2016-2021)
3.1.2 Global Nasal Polyps Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Nasal Polyps Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nasal Polyps Drugs Revenue
3.4 Global Nasal Polyps Drugs Market Concentration Ratio
3.4.1 Global Nasal Polyps Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nasal Polyps Drugs Revenue in 2020
3.5 Nasal Polyps Drugs Key Players Head office and Area Served
3.6 Key Players Nasal Polyps Drugs Product Solution and Service
3.7 Date of Enter into Nasal Polyps Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nasal Polyps Drugs Breakdown Data by Type
4.1 Global Nasal Polyps Drugs Historic Market Size by Type (2016-2021)
4.2 Global Nasal Polyps Drugs Forecasted Market Size by Type (2022-2027)
5 Nasal Polyps Drugs Breakdown Data by Application
5.1 Global Nasal Polyps Drugs Historic Market Size by Application (2016-2021)
5.2 Global Nasal Polyps Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nasal Polyps Drugs Market Size (2016-2027)
6.2 North America Nasal Polyps Drugs Market Size by Type
6.2.1 North America Nasal Polyps Drugs Market Size by Type (2016-2021)
6.2.2 North America Nasal Polyps Drugs Market Size by Type (2022-2027)
6.2.3 North America Nasal Polyps Drugs Market Size by Type (2016-2027)
6.3 North America Nasal Polyps Drugs Market Size by Application
6.3.1 North America Nasal Polyps Drugs Market Size by Application (2016-2021)
6.3.2 North America Nasal Polyps Drugs Market Size by Application (2022-2027)
6.3.3 North America Nasal Polyps Drugs Market Size by Application (2016-2027)
6.4 North America Nasal Polyps Drugs Market Size by Country
6.4.1 North America Nasal Polyps Drugs Market Size by Country (2016-2021)
6.4.2 North America Nasal Polyps Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nasal Polyps Drugs Market Size (2016-2027)
7.2 Europe Nasal Polyps Drugs Market Size by Type
7.2.1 Europe Nasal Polyps Drugs Market Size by Type (2016-2021)
7.2.2 Europe Nasal Polyps Drugs Market Size by Type (2022-2027)
7.2.3 Europe Nasal Polyps Drugs Market Size by Type (2016-2027)
7.3 Europe Nasal Polyps Drugs Market Size by Application
7.3.1 Europe Nasal Polyps Drugs Market Size by Application (2016-2021)
7.3.2 Europe Nasal Polyps Drugs Market Size by Application (2022-2027)
7.3.3 Europe Nasal Polyps Drugs Market Size by Application (2016-2027)
7.4 Europe Nasal Polyps Drugs Market Size by Country
7.4.1 Europe Nasal Polyps Drugs Market Size by Country (2016-2021)
7.4.2 Europe Nasal Polyps Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nasal Polyps Drugs Market Size (2016-2027)
8.2 Asia-Pacific Nasal Polyps Drugs Market Size by Type
8.2.1 Asia-Pacific Nasal Polyps Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nasal Polyps Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nasal Polyps Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Nasal Polyps Drugs Market Size by Application
8.3.1 Asia-Pacific Nasal Polyps Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nasal Polyps Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nasal Polyps Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Nasal Polyps Drugs Market Size by Region
8.4.1 Asia-Pacific Nasal Polyps Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nasal Polyps Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nasal Polyps Drugs Market Size (2016-2027)
9.2 Latin America Nasal Polyps Drugs Market Size by Type
9.2.1 Latin America Nasal Polyps Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Nasal Polyps Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Nasal Polyps Drugs Market Size by Type (2016-2027)
9.3 Latin America Nasal Polyps Drugs Market Size by Application
9.3.1 Latin America Nasal Polyps Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Nasal Polyps Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Nasal Polyps Drugs Market Size by Application (2016-2027)
9.4 Latin America Nasal Polyps Drugs Market Size by Country
9.4.1 Latin America Nasal Polyps Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Nasal Polyps Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nasal Polyps Drugs Market Size (2016-2027)
10.2 Middle East & Africa Nasal Polyps Drugs Market Size by Type
10.2.1 Middle East & Africa Nasal Polyps Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nasal Polyps Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nasal Polyps Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Nasal Polyps Drugs Market Size by Application
10.3.1 Middle East & Africa Nasal Polyps Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nasal Polyps Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nasal Polyps Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Nasal Polyps Drugs Market Size by Country
10.4.1 Middle East & Africa Nasal Polyps Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nasal Polyps Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Nasal Polyps Drugs Introduction
11.1.4 Pfizer Revenue in Nasal Polyps Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Nasal Polyps Drugs Introduction
11.2.4 Roche Revenue in Nasal Polyps Drugs Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Nasal Polyps Drugs Introduction
11.3.4 Sanofi Revenue in Nasal Polyps Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Nasal Polyps Drugs Introduction
11.4.4 Novartis Revenue in Nasal Polyps Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nasal Polyps Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Nasal Polyps Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Nasal Polyps Drugs Introduction
11.6.4 Merck Revenue in Nasal Polyps Drugs Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Details
11.7.2 Regeneron Pharmaceuticals Business Overview
11.7.3 Regeneron Pharmaceuticals Nasal Polyps Drugs Introduction
11.7.4 Regeneron Pharmaceuticals Revenue in Nasal Polyps Drugs Business (2016-2021)
11.7.5 Regeneron Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nasal Polyps Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Antibiotics
Table 4. Key Players of Leukotriene Inhibitors
Table 5. Key Players of Others
Table 6. Global Nasal Polyps Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nasal Polyps Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nasal Polyps Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Nasal Polyps Drugs Market Share by Regions (2016-2021)
Table 10. Global Nasal Polyps Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Nasal Polyps Drugs Market Share by Regions (2022-2027)
Table 12. Nasal Polyps Drugs Market Trends
Table 13. Nasal Polyps Drugs Market Drivers
Table 14. Nasal Polyps Drugs Market Challenges
Table 15. Nasal Polyps Drugs Market Restraints
Table 16. Global Nasal Polyps Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Nasal Polyps Drugs Market Share by Players (2016-2021)
Table 18. Global Top Nasal Polyps Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Drugs as of 2020)
Table 19. Ranking of Global Top Nasal Polyps Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Nasal Polyps Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nasal Polyps Drugs Product Solution and Service
Table 23. Date of Enter into Nasal Polyps Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Nasal Polyps Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Nasal Polyps Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Nasal Polyps Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Nasal Polyps Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Nasal Polyps Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Nasal Polyps Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Nasal Polyps Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Nasal Polyps Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Nasal Polyps Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Nasal Polyps Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Nasal Polyps Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Nasal Polyps Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Nasal Polyps Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Nasal Polyps Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Nasal Polyps Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Nasal Polyps Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Nasal Polyps Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nasal Polyps Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nasal Polyps Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nasal Polyps Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nasal Polyps Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Nasal Polyps Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Nasal Polyps Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Nasal Polyps Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Nasal Polyps Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Nasal Polyps Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Nasal Polyps Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nasal Polyps Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nasal Polyps Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nasal Polyps Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nasal Polyps Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nasal Polyps Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Nasal Polyps Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Nasal Polyps Drugs Product
Table 66. Pfizer Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Nasal Polyps Drugs Product
Table 71. Roche Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Nasal Polyps Drugs Product
Table 76. Sanofi Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Nasal Polyps Drugs Product
Table 81. Novartis Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Nasal Polyps Drugs Product
Table 86. GlaxoSmithKline Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Nasal Polyps Drugs Product
Table 91. Merck Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Regeneron Pharmaceuticals Company Details
Table 94. Regeneron Pharmaceuticals Business Overview
Table 95. Regeneron Pharmaceuticals Nasal Polyps Drugs Product
Table 96. Regeneron Pharmaceuticals Revenue in Nasal Polyps Drugs Business (2016-2021) & (US$ Million)
Table 97. Regeneron Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nasal Polyps Drugs Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Antibiotics Features
Figure 4. Leukotriene Inhibitors Features
Figure 5. Others Features
Figure 6. Global Nasal Polyps Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Nasal Polyps Drugs Report Years Considered
Figure 11. Global Nasal Polyps Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Nasal Polyps Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Nasal Polyps Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Nasal Polyps Drugs Market Share by Regions (2022-2027)
Figure 15. Global Nasal Polyps Drugs Market Share by Players in 2020
Figure 16. Global Top Nasal Polyps Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Nasal Polyps Drugs Revenue in 2020
Figure 18. Global Nasal Polyps Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Nasal Polyps Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Nasal Polyps Drugs Market Share by Type (2016-2027)
Figure 22. North America Nasal Polyps Drugs Market Share by Application (2016-2027)
Figure 23. North America Nasal Polyps Drugs Market Share by Country (2016-2027)
Figure 24. United States Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nasal Polyps Drugs Market Share by Type (2016-2027)
Figure 28. Europe Nasal Polyps Drugs Market Share by Application (2016-2027)
Figure 29. Europe Nasal Polyps Drugs Market Share by Country (2016-2027)
Figure 30. Germany Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nasal Polyps Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Nasal Polyps Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Nasal Polyps Drugs Market Share by Region (2016-2027)
Figure 40. China Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nasal Polyps Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Nasal Polyps Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Nasal Polyps Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nasal Polyps Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Nasal Polyps Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Nasal Polyps Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Nasal Polyps Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Nasal Polyps Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…- 鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
- 世界の鼻ポリープ治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nasal Polyps Treatment Market The global Nasal Polyps Treatment market size is projected to reach US$ 4233.1 million by 2027, from US$ 3377.4 million in 2020, at a CAGR of 2.8% during 2021-2027. With industry-standard accuracy in analysis and high data integrity,…
- 鼻ポリープ治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Nasal Polyps Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key playe…
- 鼻ポリープ治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Nasal Polyps Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Nasal Polyps Treatment status, future forecast, growth opportunity, key market and key playe…